[go: up one dir, main page]

Holt et al., 2007 - Google Patents

Physiology and pathophysiology of the parathyroid glands and preoperative evaluation

Holt et al., 2007

View PDF
Document ID
15301970405076987421
Author
Holt E
Inzucchi S
Publication year
Publication venue
Surgery of the thyroid and parathyroid glands

External Links

Snippet

Calcium homeostasis is of critical importance to living organisms. In man, a complex hormonal system exists to finely regulate the extracellular calcium concentration. A common aberration of this system is primary hyperparathyroidism, the leading cause of chronic …
Continue reading at ndl.ethernet.edu.et (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Ebeling et al. Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases
Shane et al. Hypercalcemia: pathogenesis, clinical manifestations, differential diagnosis, and management
Bjarnason et al. Reduced bone density in patients with inflammatory bowel disease.
Sermet-Gaudelus et al. Low bone mineral density in young children with cystic fibrosis
South-Paul Osteoporosis: part I. Evaluation and assessment
Younes et al. Laboratory screening for hyperparathyroidism
Vezzoli et al. Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria
Falorni et al. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status
Goldwasser et al. Calcium stone disease: an overview
Wit et al. A controlled trial of methionyl growth hormone therapy in prepubertal children with short stature, subnormal growth rate and normal growth hormone response to secretagogues
Ni et al. Hyperparathyroidism in a large cohort of Chinese patients with tumor-induced osteomalacia
Reusz et al. X-linked hypophosphatemia: effects of treatment with recombinant human growth hormone
Craven et al. Hypercalcemic states associated with nephrolithiasis
Holt et al. Physiology and pathophysiology of the parathyroid glands and preoperative evaluation
Moreira-Andres et al. Bone mineral status in prepubertal children with constitutional delay of growth and puberty
Zung et al. Urinary cyclic adenosine 3', 5'-monophosphate response in McCune-Albright syndrome: clinical evidence for altered renal adenylate cyclase activity
Stagi et al. Bone mineral status and metabolism in patients with Williams-Beuren syndrome
Campos et al. Parathyroid hormone and vertebral osteosclerosis in uremic patients
Lloyd et al. Adolescent Caucasian mothers have reduced adult hip bone density
Pozo et al. Growth hormone secretion in children with normal variants of short stature
Lambert Osteoporosis: a new challenge in cystic fibrosis
Kusumi et al. Promoting bone health in children and adolescents following solid organ transplantation
Irzyniec et al. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo-and hypercalciuric stone-forming patients
Salehi et al. Disorders of calcium and phosphate metabolism in infants and children
De Miguel et al. Comparison of two immunoradiometric assays for parathyroid hormone-related protein in the evaluation of cancer patients with and without hypercalcemia